Pfizer pill to treat COVID-19, China approves conditional import of Paxlovid

stick pill “Pfizer” Treating Covid-19 Paxlovid amid the epidemic Oh Micron or Omicron covid-19 mutant new strain of covid Omicron Of the most concern at this time, most recently, on Friday (February 11, 2022), the Chinese Medicine Administration gave conditional approval. Pfizer has already imported Paxlovid, a pill to treat the novel coronavirus (COVID-19), from Pfizer.

pill “Pfizer” treatment for covid-19 It is a small molecule oral drug. It contains two antiviral drugs: Nerma Trailvere (nirmatrelvir) and ritonavir (ritonavir) for treating patientsCOVID-19 adulthood with mild to moderate symptoms and those at high risk will become more ill.

China’s National Pharmaceutical Administration said that Such pills can be dispensed to elderly patients. or chronic kidney disease, diabetes, cardiovascular disease and chronic lung disease Patients should take the medication as prescribed by the doctor and closely observe drug interactions.

The National Bureau of Medicine of China Ask the holder of a marketing license of pill “Pfizer” treatment for covid-19 This one continues the relevant research. fulfill the conditions within the specified time and submit research results on time

(image fileXinhua : Medical personnel collect secretions for testing for COVID-19 from a man in Xiamen East China’s Fujian Province, August 2, 2021)

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.